Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

107.52
Delayed Data
As of Jul 22
 +0.07 / +0.07%
Today’s Change
92.98
Today|||52-Week Range
140.72
-10.22%
Year-to-Date
I Just Bought These 4 Fast-Growing Biotech Stocks
Jul 23 / MotleyFool.com - Paid Partner Content
Celgene's Revlimid Gains EU Nod for Mantle Cell Lymphoma
Jul 18 / Zacks.com - Paid Partner Content
Celgene (CELG) Stock Is the 'Chart of the Day'
Jul 22 / TheStreet.com - Paid Partner Content
Does Biogen's Lower P/E Ratio Make It a Better Buy Than Celgene?
Jul 15 / MotleyFool.com - Paid Partner Content
Stock Market News for July 21, 2016
Jul 21 / Zacks.com - Paid Partner Content
How Much Do Stock Prices Matter in Biotech?
Jul 14 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Zafgen, Celgene, Amgen, AbbVie and Biogen
Jul 21 / Zacks.com - Paid Partner Content
The 3 Most Unbelievably Undervalued Healthcare Stocks
Jul 13 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Celgene in Immuno-Oncology Deal, Zafgen Drops Lead Drug
Jul 20 / Zacks.com - Paid Partner Content
Which Pipeline Has Better Potential: Celgene or Biogen?
Jul 12 / MotleyFool.com - Paid Partner Content
Celgene (CELG), Jounce Strike Immunotherapy Collaboration
Jul 20 / Zacks.com - Paid Partner Content
Cancer drug trial deaths hit biotech industry
Jul 08 / FT.com - Paid Partner Content
3 Perfect Stocks for People in Their 40s to Consider Buying
Jul 20 / MotleyFool.com - Paid Partner Content
Medivation: scarcity value
Jul 06 / FT.com - Paid Partner Content
3 Biotech Stocks to Buy and Hold
Jul 19 / MotleyFool.com - Paid Partner Content
Medivation confident drugs pipeline will win over suitors
Jul 06 / FT.com - Paid Partner Content
Celgene, Jounce Therapeutics in Early Cancer Immunotherapy Development Pact
Jul 19 / TheStreet.com - Paid Partner Content
Wall Street set for best week since late 2014 as stocks rebound
Jul 01 / FT.com - Paid Partner Content
Celgene to partner Jounce in battle against cancerous cells
Jul 19 / FT.com - Paid Partner Content